Magnesium Anxiety Meta-analysis: What the Evidence Says

Quick Answer

Magnesium Anxiety Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are mixed biomedical and public-health sources, so conclusions should be framed as evidence-aware guidance rather than medical advice.

Key Takeaways

• This page is generated only from sources stored in the Migaku evidence knowledge base.
• Current evidence mix: 2 narrative review.
• Claims should be interpreted with the source type, study design, population, and publication date in mind.
• This article is educational and does not replace care from a qualified clinician.

Evidence Map

What The Sources Report

• A comprehensive review of psychiatric presentations reported that psychiatric symptoms span attention problems, anxiety, mood/behavioral disorders, and psychosis and identified > 100 IEMs associated with psychiatric manifestations; in a curated analysis, 94 IEMs were linked to psychiatric symptoms, with mood changes ranging from depressive syndromes to bipolar-like presentations. [Hachmeriyan Antoniya (2026); evidence level 3]
• Clinically, mood disorders associated with IEMs often exhibit characteristic diagnostic patterns that may aid early recognition. [Hachmeriyan Antoniya (2026); evidence level 3]
• Thus, this review aims to integrate advances in magnesium physiology with contemporary clinical and nutritional evidence, providing a consolidated strategy for understanding the causes, manifestations, diagnosis, and management of hypomagnesemia. [Papagiannidou Anastasia (2026); evidence level 3]
• Finally, we also cover practical laboratory assessment and evidence-informed repletion strategies. [Papagiannidou Anastasia (2026); evidence level 3]

How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

Practical Interpretation

For magnesium anxiety meta-analysis, the current source set is useful for orientation, but it is not yet broad enough for strong claims. Use cautious language and keep conclusions close to the cited sources.

Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

References

• Hachmeriyan Antoniya (2026). From Plate to Mind: Scientific Perspectives on Foods That May Influence Anxiety and Depression. DOI: 10.3390/nu18091318. PMCID: PMC13165168. PMID: 42123920. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13165168/
• Papagiannidou Anastasia (2026). Hypomagnesemia: A Clinical and Nutritional Update. DOI: 10.1007/s13668-026-00745-5. PMCID: PMC13009017. PMID: 41872423. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13009017/

Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.